1
|
Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
|
Science
|
2011
|
6.19
|
2
|
Induction of cachexia in mice by systemically administered myostatin.
|
Science
|
2002
|
4.39
|
3
|
Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
|
Proc Natl Acad Sci U S A
|
2005
|
3.52
|
4
|
The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum.
|
J Biol Chem
|
2002
|
3.01
|
5
|
Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.
|
Biochem Biophys Res Commun
|
2003
|
2.82
|
6
|
Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells.
|
J Biol Chem
|
2007
|
2.06
|
7
|
The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex.
|
J Immunol
|
2008
|
1.82
|
8
|
Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains.
|
Mol Endocrinol
|
2003
|
1.68
|
9
|
Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2.
|
Int Immunopharmacol
|
2004
|
1.56
|
10
|
IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22.
|
J Mol Biol
|
2008
|
0.97
|
11
|
A fluorescent assay suitable for inhibitor screening and vanin tissue quantification.
|
Anal Biochem
|
2009
|
0.93
|
12
|
Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys.
|
Rheumatology (Oxford)
|
2011
|
0.75
|